The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EMN 2018 | Biomarkers of amyloidosis
Giampaolo Merlini
• 4 May 2018
New insights into amyloid light-chain (AL) amyloidosis have emerged in recent years. Here, Giampaolo Merlini, MD, from the University of Pavia, Paiva, Italy, gives an overview of the mechanisms behind this rare condition at the 1st European Myeloma Network Meeting (EMN), in Turin, Italy. Dr Merlini then discusses the importance of biomarkers in the reflection of pathogenic mechanisms of AL amyloidosis, highlighting key biomarkers, such as NT-proBNP and GDF-15.
